कृपया अन्य खोज का प्रयास करें
Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. Its lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, that is in Phase 2b/3 clinical trial, to prevent esophageal varices in patient with non-alcoholic steatohepatitis (NASH) cirrhosis; and Phase 2 clinical trial for the treatment of liver fibrosis, as well as severe skin disease, and melanoma and head and neck squamous cell carcinoma. The company, through its Galectin Sciences, LLC, which is a collaborative joint venture co-owned by SBH Sciences, Inc., to research and develop small organic molecule inhibitors of galectin-3 for oral administration. The company was formerly known as Pro-Pharmaceuticals, Inc. and changed its name to Galectin Therapeutics, Inc. in May 2011. Galectin Therapeutics Inc. was founded in 2000 and is based in Norcross, Georgia.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Kary Eldred | 50 | 2018 | Independent Director |
Kevin H. Mayo | - | - | Member of the Scientific Board |
Eric Lawitz | - | - | Member of Clinical Advisory Board |
Benjamin S. Carson | 73 | 2023 | Independent Director |
Marc Rubin | 69 | 2011 | Independent Director |
Gilbert F. Amelio | 81 | 2009 | Independent Director |
Kevin D. Freeman | 62 | 2011 | Independent Vice Chairman of the Board |
Anatole A. Klyosov | 77 | 2000 | Co-founder & Member of the Scientific Board |
Stephen A. Harrison | - | - | Member of Clinical Advisory Board |
Brent Tetri | - | - | Member of Clinical Advisory Board |
Richard E. Uihlein | 79 | 2017 | Independent Chairman |
Naga Chalasani | - | - | Member of Clinical Advisory Board |
Joel Lewis | 54 | 2017 | President, CEO & Director |
Thomas D. Schiano | - | - | Member of Clinical Advisory Board |
Ram Subramanian | - | - | Member of Clinical Advisory Board |
Arun J. Sanyal | - | - | Member of Clinical Advisory Board |
Elissa J. Schwartz | 53 | 2020 | Independent Director |
Richard A. Zordani | 51 | 2020 | Independent Director |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है